Ebola surge tests global response as FDA leadership reshapes U.S. health policy
The Ebola outbreak in the Democratic Republic of Congo is worsening and likely undercounted, with spread to Uganda and a Rwanda travel ban for those linked to the DRC, though experts say travel bans don’t stop spread. Momentum for a dedicated U.S. men’s health office remains uncertain ahead of midterms. Acting FDA Commissioner Kyle Diamantas is consolidating leadership amid a reshuffle. A Lancet study puts global mental disorders at 1.17 billion in 2023, underscoring rising need. Eight former CDC directors warn against hasty changes to PEPFAR, arguing the program’s evolution must be careful to preserve its gains.